Portfolio company
Perseus Proteomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops antibody-based therapeutics, research reagents and diagnostic kits for the global healthcare and pharmaceutical sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
ybiologics
The company develops antibody-based therapeutics and immuno-oncology drugs for pharmaceutical partners and the global healthcare sector.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
Protuoso Biosciences
This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.
Enzo Biochem
This company produces research reagents, including antibodies, assays and proteins, for academic research, biotechnology, pharmaceutical and diagnostic customers.
Redwood Bioscience
The company develops protein-chemical engineering technology for producing antibody-drug conjugates and semi-synthetic biotherapeutics for pharmaceutical and biotechnology researchers.
Ciphergen Biosystems
The company develops protein chips and proteomics analysis tools for pharmaceutical firms, biotechnology companies, and research institutions.
Third Arc Bio
This biotechnology company develops multifunctional antibodies to treat solid tumours and inflammatory diseases for the healthcare sector.
